English | Español
Jamie Barrand | Dec 17, 2015

AstraZeneca acquires rights to market Crohn's disease medication
Jamie Barrand | Dec 17, 2015

FDA approves antidote for muscle relaxants used in breathing tube insertion
Jamie Barrand | Dec 17, 2015

Allergan releases new therapy for irritable bowel syndrome
Jamie Barrand | Dec 17, 2015

Narcan Nasal Spray approved by FDA for treatment of opioid overdose
Jamie Barrand | Dec 17, 2015

AstraZeneca acquires core respiratory business of Takeda Pharmaceuticals
Jamie Barrand | Dec 16, 2015

FDA approves first-ever treatment for chemotherapy overdose
Jamie Barrand | Dec 16, 2015

Bristol-Myers Squibb, UCLA team up for cancer research

Jamie Barrand | Dec 16, 2015

FDA approves new therapy for advanced lung cancer

Trending
+ Pharmaceuticals
Patient Daily | Jun 30, 2025

PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

PhRMA chief public affairs officer on 340B drug pricing: ‘Lowering drug prices for U.S. patients starts by reining in middlemen’
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

American Lung Association launches campaign for World Bronchiectasis Day
+ Pharmaceuticals
Patient Daily | Jun 25, 2025

Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’